The Procter & Gamble Company
As of Fiscal Year 2026 (ended June 30, 2026)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total net sales (FY2026) | $87.03 billion, up 3% year-over-year |
| Net earnings attributable to P&G (FY2026) | $16.05 billion, up slightly from $15.97 billion in FY2025 |
| Diluted EPS (FY2026) | $6.62, up from $6.51 in FY2025 |
| Core EPS, non-GAAP (FY2026) | $6.89 |
| Organic sales growth (FY2026) | +1% company-wide |
| Gross margin (FY2026) | 50.2% |
| Corporate segment net loss (FY2026) | $(23) million -- reconciling/unallocated corporate items, the only segment with a loss |
| Dividend per share (FY2026) | $4.2589 |
| Employees (as of June 30, 2026) | approximately 104,000, down 4% year-over-year due to an ongoing restructuring program |
Sources: Segment net sales and net earnings figures are from P&G's Q4/FY2026 earnings release (SEC Form 8-K Exhibit 99.1, reported July 29, 2026) and FY2026 Form 10-K. P&G's Corporate segment posted a small net loss in FY2026; per methodology, a segment with a loss is excluded from the net-earnings pie chart (a pie cannot show a negative slice) and instead called out in the KPI table. No specifically-attributed third-party category market-share estimate could be confidently sourced this cycle, so none is included.